Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Quest Diagnostics    DGX

QUEST DIAGNOSTICS

(DGX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Cabot, Clorex rise; Marathon Oil, Wells Fargo fall

share with twitter share with LinkedIn share with facebook
share via e-mail
03/09/2020 | 03:18pm EDT

NEW YORK — Stocks that moved heavily or traded substantially on Monday:

Quest Diagnostics Inc., down $2.18 to $109.84.

Medical diagnostics companies held up better than the broader market as the virus outbreak increases the need for testing services.

Marathon Oil Corp., down $3.20 to $3.63.

The price of oil plunged as major crude-producing nations clashed over production plans.

Wells Fargo & Co., down $4.61 to $32.48.

The troubled bank said the chairwoman of its board of directors has resigned.

Royal Caribbean Cruises Ltd., down $16.74 to $48.27.

The U.S. urged citizens to avoid cruise ships because of the increased risk of infection.

Cabot Oil & Gas Corp., up 52 cents to $16.89.

The natural gas producer gained as gas prices fared better than crude oil prices.

Clorox Co., up $1.64 to $174.90.

Sales of disinfectants have surged as the virus outbreak spreads.

Thor Industries Inc., down $18.77 to $51.27.

The company's fiscal second-quarter profit fell short of Wall Street forecasts.

Mylan N.V., down $1.02 to $14.38.

The company's own version of the cancer drug Avastin is being reviewed by U.S. regulators.

© 2020 The Canadian Press. All rights reserved., source Canadian Press DataFile

Stocks mentioned in the article
ChangeLast1st jan.
CABOT OIL & GAS CORPORATION 1.45% 18.9 Delayed Quote.8.56%
MARATHON OIL CORPORATION -0.84% 5.89 Delayed Quote.-56.63%
QUEST DIAGNOSTICS -0.14% 112.83 Delayed Quote.5.66%
WELLS FARGO & COMPANY -1.19% 24.17 Delayed Quote.-55.07%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on QUEST DIAGNOSTICS
05/21QUEST DIAGNOSTICS : Form4
PU
05/21QUEST DIAGNOSTICS INC : Submission of Matters to a Vote of Security Holders (for..
AQ
05/20QUEST DIAGNOSTICS : Governor Murphy, Walmart, and Quest Diagnostics Announce Par..
PU
05/20QUEST DIAGNOSTICS : Arkansas Health & Wellness, Arkansas Total Care and Quest Di..
PR
05/18QUEST DIAGNOSTICS : Declares Quarterly Cash Dividend
PR
05/13QUEST DIAGNOSTICS INC : Entry into a Material Definitive Agreement, Other Events..
AQ
05/11QUEST DIAGNOSTICS : Prices $550 Million of Senior Notes
PR
05/11ORTHO CLINICAL DIAGNOSTICS : and Quest Diagnostics to Broaden Availability of CO..
PR
05/08PEACH STATE HEALTH PLAN : and Quest Diagnostics Team Up to Increase Access to CO..
PR
05/05QUEST DIAGNOSTICS : to Hold Virtual Annual Meeting of Stockholders
PR
More news
Financials (USD)
Sales 2020 7 215 M
EBIT 2020 833 M
Net income 2020 507 M
Debt 2020 3 548 M
Yield 2020 1,97%
P/E ratio 2020 30,5x
P/E ratio 2021 17,9x
EV / Sales2020 2,58x
EV / Sales2021 2,32x
Capitalization 15 089 M
Chart QUEST DIAGNOSTICS
Duration : Period :
Quest Diagnostics Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QUEST DIAGNOSTICS
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 117,40 $
Last Close Price 112,83 $
Spread / Highest target 29,4%
Spread / Average Target 4,05%
Spread / Lowest Target -20,2%
EPS Revisions
Managers
NameTitle
Stephen H. Rusckowski Chairman, President & Chief Executive Officer
Mark J. Guinan Chief Financial Officer & Executive Vice President
Jay G. Wohlgemuth Chief Medical Officer, Senior VP-R&D, Medical
Gabrielle Wolfson SVP, Chief Information & Digital Officer
Gail R. Wilensky Independent Director